Hester Biosciences Schedules Q2 & H1 FY27 Earnings Conference Call
Hester Biosciences Ltd 路 Intimation 路 05 Nov 2026, 2:00 pm
Hester Biosciences Schedules Q2 & H1 FY27 Earnings Conference Call Hester Biosciences Limited will host an earnings conference call on 5th Nov'26 at 2:00 PM IST to discuss its financial performance for the quarter and half-year ended 30th Sep'26 (Q2 & H1 FY27). The call is organized by ICICI Securities and will feature senior management, including CEO & Managing Director Rajiv Gandhi, Executive Director Priya Gandhi, and CFO Ashish Desai.
Original exchange filing (PDF)
More announcements from Hester Biosciences Ltd
- 20261105 Transcript of Earnings Conference Call for Q2 & H1 FY27 Financial Results 路 07 Nov 2026
- Audio recording of the Earnings Conference Call for Q2 FY 27 路 05 Nov 2026
- Hester Biosciences Limited has informed the Exchange about Board have approved an Unsecured loan of an aggregate amount of USD 1 million to Hester Biosciences Africa Limited( Hester Africa ), foreign wholly-owned subsidiary in Tanzania, in one or more tranches. 路 05 Nov 2026
- Disclosure under regulation 30 of Listing Regulations - Board of Directors approved an unsecured loan to Hester Biosciences Africa Limited, Foreign wholly-owned subsidiary of the Company. 路 05 Nov 2026
- Hester Biosciences Limited has informed the Exchange regarding a press release dated November 05, 2026, titled "20261105 Q2 & H1 FY27 Press Release". 路 05 Nov 2026
- 20261105 Q2 & H1 FY27 Press Release 路 05 Nov 2026
- Hester Biosciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- Outcome of Board Meeting held on 5 November 2026 and Financial Results for the Q2 & H1 FY 2026-27 路 05 Nov 2026
